Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd

<< Previous

Bullboard Posts

Next >>

Post by fredskion Jan 18, 2013 7:48am

294 Views

Post# 20855126

Québec Greenstone Belt - The Players & Maps

Québec Greenstone Belt - The Players & Maps
Read more at https://www.stockhouse.com/blogs/viewdetailedpost.aspx?p=157766#7r4mWMeY7elDY9Rg.99

THE ABITIBI GREENSTONE BELT (AGB)

The Abitibi Greenstone Belt is unique amongst the greenstone belts of the Canadian Shield in that it has a high ratio of supracrustal to intrusive rocks. It has a generally low metamorphic grade and is known to have a diverse spectrum of richly mineralized deposits. The belt is found in both provinces of Ontario and Quebec with approximately 33% in Ontario and 67% in Quebec. The Belt has produced in excess of 180,000,000 ounces of gold and more than 450,000,000 tons of Cu-Zn ore to date.